‘Chemobrein’ can be up to six months after treatment breast cancer continue to
Breast cancer patients can be up to half a year after their chemotherapy keep having cognitive impairments such as forgetfulness and decreased concentration.
This phenomenon, visible in the brain, is also called chemobrein called.
Researchers from the cancer institute of the University of Rochester in the United States is doing research under 581 female breast cancer patients and compared them with 364 healthy people. In both groups, the average age was 53.
The scientists used a special technique to the cognitive performance measure. The breast cancer patients showed subsequent 45 percent more cognitive limitations.
When a data point half a year later showed that over one in three women still suffer from chemobrein, and that the symptoms even worsened were in that period. In the healthy group, this was at a on the eight the case.
The condition seems to be strengthened if the period after the chemotherapy is accompanied with feelings of anxiety, stress and depression. Also had the younger patients in the test group relatively more burden of a chemobrein.